Hiroshi Fujishima
About
In The Last Decade
Hiroshi Fujishima
180 papers receiving 5.0k citations
Peers
Comparison fields: 5 of 143
- Public Health, Environmental and Occupational Health 2.8k
- Radiology, Nuclear Medicine and Imaging 1.5k
- Ophthalmology 1.4k
- Immunology and Allergy 1.1k
- Dermatology 696
Countries citing papers authored by Hiroshi Fujishima
This map shows the geographic impact of Hiroshi Fujishima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Fujishima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Fujishima more than expected).
Fields of papers citing papers by Hiroshi Fujishima
This network shows the impact of papers produced by Hiroshi Fujishima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Fujishima. The network helps show where Hiroshi Fujishima may publish in the future.
Co-authorship network of co-authors of Hiroshi Fujishima
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Fujishima. A scholar is included among the top collaborators of Hiroshi Fujishima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Fujishima. Hiroshi Fujishima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Innovative artificial intelligence-based cataract diagnostic method uses a slit-lamp video recording device and multiple machine-learning | 1 |
| 2 | 141 | |
| 3 | 38 | |
| 4 | 38 | |
| 5 | Steroid sparing effect of 0.1% tacrolimus eye drops for treatment of shield ulcer and corneal epitheliopathy in refractory allergic ocular diseases | 0 |
| 6 | 54 | |
| 7 | The Efficacy of Topical Tacrolimus Hydrate in Patients With AKC/VKC | 1 |
| 8 | In vivo Investigation of the Cornea in Atopic Keratoconjunctivitis Patients Using Confocal Laser Scanning Microscopy | 1 |
| 9 | The Change of Prostaglandins,and Cysteinyl-leukotriene Concentrations in the Tears of Patients With Severe Allergic Conjunctivitis | 1 |
| 10 | Preliminary Results of the World Ocular Allergy Study: Comparison of the Characteristics of Patients With Severe Ocular Allergies in Italy and Japan | 1 |
| 11 | The Efficacy of FK506 Eye–Drop in the Treatment of Ocular Surface Complications in Patients With Severe Allergic Patients With Corneal Complications | 1 |
| 12 | CRTH2 expression on eosinophils from atopic patients | 2 |
| 13 | PGD2 Concentration in Tears of Patients With Severe Allergic Conjunctival Diseases | 1 |
| 14 | Cromoglicic Acid Ophthalmic Solution 2% Versus Levocabastine Ophthalmic Suspension 0.025% in the Treatment of Allergic Conjunctivitis | 1 |
| 15 | Neutrophil Chemoattractants in the Tears of Patients With Severe Allergic Conjunctival Diseases | 1 |
| 16 | 35 | |
| 17 | Open loop anterior chamber intraocular lens implantation with penetrating keratoplasty | 1 |
| 18 | A multicenter study on definite and probably dry eyes | 1 |
| 19 | Staining test of the ocular surface at predetermined dye concentration and volume | 2 |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.